Profile data is unavailable for this security.
About the company
PetMed Express, Inc. is a pet pharmacy, which is engaged in delivering prescription and non-prescription pet medications and other health products for dogs, cats and horses through its website at petmeds.com, as well as through its toll-free number. The Company's product line contains approximately 3,000 SKUs of pet medications, health products, and supplies. It offers various pet supplies, including food, beds, crates, stairs and other pet supplies. The Company's products include Non-Prescription Medications (OTC) and supplies, and Prescription Medications (Rx). OTC and supplies include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies. Rx includes heartworm and flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.
- Revenue in USD (TTM)262.30m
- Net income in USD15.68m
- Incorporated1996
- Employees212.00
- LocationPetmed Express Inc420 South Congress AvenueDELRAY BEACH 33445United StatesUSA
- Phone+1 (561) 426-4444
- Fax+1 (800) 600-8285
- Websitehttps://www.1800petmeds.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Homology Medicines Inc | 3.21m | -4.29m | 88.52m | 224.00 | -- | 0.4234 | 30.16 | 27.59 | -0.0915 | -0.0915 | 0.0559 | 3.64 | 0.013 | -- | -- | 14,321.43 | -0.0657 | -38.19 | -0.0721 | -41.16 | -- | -- | -5.05 | -948.08 | -- | -- | 0.00 | -- | 1,157.25 | -- | 25.59 | -- | 3.79 | -- |
| CareRx Corp | 286.55m | -25.44m | 95.01m | 1.38k | -- | 2.13 | -- | 0.3316 | -0.7298 | -0.7298 | 8.27 | 1.24 | 1.42 | 13.98 | 9.82 | 278,852.00 | -12.64 | -17.30 | -15.90 | -36.93 | 28.69 | 29.97 | -8.88 | -15.99 | 1.20 | 0.6716 | 0.70 | -- | 61.92 | 9.43 | -25.01 | -- | 19.31 | -- |
| Tabula Rasa HealthCare Inc | 302.49m | -80.33m | 122.06m | 1.60k | -- | -- | -- | 0.4035 | -3.36 | -5.81 | 12.65 | -1.17 | 0.6686 | 42.44 | 7.82 | 188,822.10 | -17.76 | -12.97 | -21.67 | -15.22 | 23.80 | 31.98 | -26.56 | -18.17 | 1.78 | -6.37 | 1.11 | -- | 11.45 | 28.43 | 2.36 | -- | 43.94 | -- |
| High Tide Inc | 225.56m | -17.67m | 130.68m | -- | -- | 0.8738 | 51.09 | 0.5794 | -0.3972 | -0.3972 | 5.11 | 2.87 | 1.11 | 11.07 | 34.38 | -- | -8.28 | -- | -10.07 | -- | 29.42 | -- | -7.45 | -- | 0.7777 | -5.05 | 0.2378 | -- | 117.53 | -- | -412.59 | -- | -- | -- |
| Marimed Inc | 129.22m | 2.21m | 180.37m | 260.00 | 156.32 | 3.38 | 27.04 | 1.40 | 0.0034 | 0.0034 | 0.351 | 0.2685 | 0.9829 | 4.48 | 16.93 | 497,014.90 | 1.87 | -27.01 | 2.28 | -39.39 | 49.24 | 54.25 | 1.90 | -36.53 | 0.8284 | 20.64 | 0.2289 | -- | 138.66 | 102.53 | 236.97 | -- | 40.72 | -- |
| HLS Therapeutics Inc | 61.48m | -21.36m | 231.52m | 94.00 | -- | 1.76 | 18.68 | 3.77 | -0.8825 | -0.8825 | 2.54 | 5.44 | 0.2302 | 0.4627 | 6.90 | 896,100.10 | -8.00 | -5.38 | -9.03 | -6.09 | 92.54 | 94.70 | -34.74 | -25.72 | 1.14 | -3.02 | 0.4313 | -- | 6.95 | -- | 14.44 | -- | -- | -- |
| Rite Aid Corporation | 24.21bn | -866.60m | 286.63m | 53.00k | -- | -- | -- | 0.0118 | -15.94 | -15.94 | 445.71 | -5.95 | 2.73 | 9.84 | 15.01 | 456,791.00 | -9.78 | -3.96 | -14.30 | -5.77 | 20.35 | 21.12 | -3.58 | -1.58 | 0.6083 | 0.5526 | 1.12 | -- | 2.18 | 1.39 | -438.10 | -- | -5.56 | -- |
| Petmed Express Inc | 262.30m | 15.68m | 417.30m | 212.00 | 25.67 | 3.02 | 22.33 | 1.59 | 0.7712 | 0.7712 | 12.91 | 6.55 | 1.60 | 6.95 | 152.32 | 1,237,264.00 | 9.54 | 19.33 | 11.13 | 23.28 | 28.79 | 31.07 | 5.98 | 10.54 | 3.41 | -- | 0.00 | 72.36 | -11.58 | 1.87 | -31.05 | -2.40 | -30.24 | 9.57 |
| Neighbourly Pharmacy Inc | 406.23m | 4.63m | 812.76m | 2.04k | 134.47 | 1.78 | 28.15 | 2.00 | 0.1853 | 0.1853 | 14.99 | 14.04 | 0.673 | 4.94 | 20.19 | 267,558.00 | 0.9049 | -- | 1.02 | -- | 37.70 | -- | 1.34 | -- | 0.6005 | 2.00 | 0.3228 | -- | 39.48 | -- | 19.68 | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 30 Sep 2022 | 3.07m | 14.62% |
| The Vanguard Group, Inc.as of 30 Sep 2022 | 1.48m | 7.03% |
| Renaissance Technologies LLCas of 30 Sep 2022 | 970.77k | 4.62% |
| SSgA Funds Management, Inc.as of 30 Sep 2022 | 927.68k | 4.42% |
| Charles Schwab Investment Management, Inc.as of 30 Sep 2022 | 572.71k | 2.73% |
| Dimensional Fund Advisors LPas of 30 Sep 2022 | 566.00k | 2.69% |
| Global X Management Co. LLCas of 30 Sep 2022 | 564.70k | 2.69% |
| ProShare Advisors LLCas of 30 Sep 2022 | 513.34k | 2.44% |
| BNP Paribas Asset Management USA, Inc.as of 30 Sep 2022 | 474.90k | 2.26% |
| Oaktop Capital Management II LPas of 30 Sep 2022 | 435.84k | 2.07% |
